Sigba, Cjay .
HRN: 22-77-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2023
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
03/28/2023
04/03/2023
ORAL
1.5mg
Q12
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes